COVID-19 Impact on Insulin Delivery Pens Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Insulin Delivery Pens, including the following market information:

    Global Insulin Delivery Pens Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)

    Global Insulin Delivery Pens Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

Key market players

Major competitors identified in this market include Novo Nordisk, Sanofi Diabetes, Medtronic, BD, Animas, Roche, Insulet, Bomtech, BioSampling, Cardiocomm Solutions, Henke-Sass, Kavo, Megasan Medical, Nipro, Mika Medical, Rudolf Riester, Smiths Medical, etc.

Based on the Region:

    Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    North America (US and Canada)

    Europe (Germany, France, UK and Italy)

    Rest of World (Latin America, Middle East & Africa)

Based on the Type:

    Reusable Insulin Pens

    Disposable Insulin Pens

Based on the Application:

    Hospital Pharmacy

    Retail Pharmacy

    Online Sales

    Diabetes Clinics

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Insulin Delivery Pens Industry

1.7 COVID-19 Impact: Insulin Delivery Pens Market Trends

2.1 Insulin Delivery Pens Business Impact Assessment - COVID-19

2.1.1 Global Insulin Delivery Pens Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Insulin Delivery Pens Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Insulin Delivery Pens Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3.1 Global Insulin Delivery Pens Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Insulin Delivery Pens Factory Price by Manufacturers

3.3 Location of Key Manufacturers Insulin Delivery Pens Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Insulin Delivery Pens Market

3.5 Key Manufacturers Insulin Delivery Pens Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4.1 Introduction

1.4.1 Reusable Insulin Pens

1.4.2 Disposable Insulin Pens

4.2 By Type, Global Insulin Delivery Pens Market Size, 2019-2021

4.2.1 By Type, Global Insulin Delivery Pens Market Size by Type, 2020-2021

4.2.2 By Type, Global Insulin Delivery Pens Price, 2020-2021

5.1 Overview

5.5.1 Hospital Pharmacy

5.5.2 Retail Pharmacy

5.5.3 Online Sales

5.5.4 Diabetes Clinics

5.2 By Application, Global Insulin Delivery Pens Market Size, 2019-2021

5.2.1 By Application, Global Insulin Delivery Pens Market Size by Application, 2019-2021

5.2.2 By Application, Global Insulin Delivery Pens Price, 2020-2021

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7.1 Novo Nordisk

7.1.1 Novo Nordisk Business Overview

7.1.2 Novo Nordisk Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.1.3 Novo Nordisk Insulin Delivery Pens Product Introduction

7.1.4 Novo Nordisk Response to COVID-19 and Related Developments

7.2 Sanofi Diabetes

7.2.1 Sanofi Diabetes Business Overview

7.2.2 Sanofi Diabetes Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.2.3 Sanofi Diabetes Insulin Delivery Pens Product Introduction

7.2.4 Sanofi Diabetes Response to COVID-19 and Related Developments

7.3 Medtronic

7.3.1 Medtronic Business Overview

7.3.2 Medtronic Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.3.3 Medtronic Insulin Delivery Pens Product Introduction

7.3.4 Medtronic Response to COVID-19 and Related Developments

7.4 BD

7.4.1 BD Business Overview

7.4.2 BD Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.4.3 BD Insulin Delivery Pens Product Introduction

7.4.4 BD Response to COVID-19 and Related Developments

7.5 Animas

7.5.1 Animas Business Overview

7.5.2 Animas Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.5.3 Animas Insulin Delivery Pens Product Introduction

7.5.4 Animas Response to COVID-19 and Related Developments

7.6 Roche

7.6.1 Roche Business Overview

7.6.2 Roche Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.6.3 Roche Insulin Delivery Pens Product Introduction

7.6.4 Roche Response to COVID-19 and Related Developments

7.7 Insulet

7.7.1 Insulet Business Overview

7.7.2 Insulet Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.7.3 Insulet Insulin Delivery Pens Product Introduction

7.7.4 Insulet Response to COVID-19 and Related Developments

7.8 Bomtech

7.8.1 Bomtech Business Overview

7.8.2 Bomtech Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.8.3 Bomtech Insulin Delivery Pens Product Introduction

7.8.4 Bomtech Response to COVID-19 and Related Developments

7.9 BioSampling

7.9.1 BioSampling Business Overview

7.9.2 BioSampling Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.9.3 BioSampling Insulin Delivery Pens Product Introduction

7.9.4 BioSampling Response to COVID-19 and Related Developments

7.10 Cardiocomm Solutions

7.10.1 Cardiocomm Solutions Business Overview

7.10.2 Cardiocomm Solutions Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.10.3 Cardiocomm Solutions Insulin Delivery Pens Product Introduction

7.10.4 Cardiocomm Solutions Response to COVID-19 and Related Developments

7.11 Henke-Sass

7.11.1 Henke-Sass Business Overview

7.11.2 Henke-Sass Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.11.3 Henke-Sass Insulin Delivery Pens Product Introduction

7.11.4 Henke-Sass Response to COVID-19 and Related Developments

7.12 Kavo

7.12.1 Kavo Business Overview

7.12.2 Kavo Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.12.3 Kavo Insulin Delivery Pens Product Introduction

7.12.4 Kavo Response to COVID-19 and Related Developments

7.13 Megasan Medical

7.13.1 Megasan Medical Business Overview

7.13.2 Megasan Medical Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.13.3 Megasan Medical Insulin Delivery Pens Product Introduction

7.13.4 Megasan Medical Response to COVID-19 and Related Developments

7.14 Nipro

7.14.1 Nipro Business Overview

7.14.2 Nipro Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.14.3 Nipro Insulin Delivery Pens Product Introduction

7.14.4 Nipro Response to COVID-19 and Related Developments

7.15 Mika Medical

7.15.1 Mika Medical Business Overview

7.15.2 Mika Medical Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.15.3 Mika Medical Insulin Delivery Pens Product Introduction

7.15.4 Mika Medical Response to COVID-19 and Related Developments

7.16 Rudolf Riester

7.16.1 Rudolf Riester Business Overview

7.16.2 Rudolf Riester Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.16.3 Rudolf Riester Insulin Delivery Pens Product Introduction

7.16.4 Rudolf Riester Response to COVID-19 and Related Developments

7.17 Smiths Medical

7.17.1 Smiths Medical Business Overview

7.17.2 Smiths Medical Insulin Delivery Pens Quarterly Production and Revenue, 2020

7.17.3 Smiths Medical Insulin Delivery Pens Product Introduction

7.17.4 Smiths Medical Response to COVID-19 and Related Developments

8.1 Insulin Delivery Pens Supply Chain Analysis

8.1.1 Insulin Delivery Pens Supply Chain Analysis

8.1.2 Covid-19 Impact on Insulin Delivery Pens Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Insulin Delivery Pens Distribution Channels

8.2.2 Covid-19 Impact on Insulin Delivery Pens Distribution Channels

8.2.3 Insulin Delivery Pens Distributors

8.3 Insulin Delivery Pens Customers

10.1 About Us

10.2 Disclaimer

List of Tables

    Table 1. Overview of the World Economic Outlook Projections

    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 7. Covid-19 Impact: Global Major Government Policy

    Table 8. The Covid-19 Impact on Insulin Delivery Pens Assessment

    Table 9. COVID-19 Impact: Insulin Delivery Pens Market Trends

    Table 10. COVID-19 Impact Global Insulin Delivery Pens Market Size

    Table 11. Global Insulin Delivery Pens Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (K Units)

    Table 12. Global Insulin Delivery Pens Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/Unit)

    Table 13. Global Insulin Delivery Pens Quarterly Market Size, 2020 (US$ Million) & (K Units)

    Table 14. Global Insulin Delivery Pens Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

    Table 15. Global Insulin Delivery Pens Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (K Units)

    Table 16. Global Insulin Delivery Pens Market Growth Drivers

    Table 17. Global Insulin Delivery Pens Market Restraints

    Table 18. Global Insulin Delivery Pens Market Opportunities

    Table 19. Global Insulin Delivery Pens Market Challenges

    Table 20. Key Manufacturers Insulin Delivery Pens Quarterly Revenue, 2019 VS 2020 (US$ Million)

    Table 21. Top Manufacturers, Insulin Delivery Pens Market Size, 2019 (K Units) & (US$ Million)

    Table 22. Insulin Delivery Pens Factory Price by Manufacturers 2020 (USD/Unit)

    Table 23. Location of Key Manufacturers Insulin Delivery Pens Manufacturing Plants

    Table 24. Key Manufacturers Insulin Delivery Pens Market Served

    Table 25. Date of Key Manufacturers Enter into Insulin Delivery Pens Market

    Table 26. Key Manufacturers Insulin Delivery Pens Product Type

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Insulin Delivery Pens Market Size by Type, 2020, (US$ Million)

    Table 29. Global Insulin Delivery Pens Market Size by Type, 2020 (K Units)

    Table 30. Global Insulin Delivery Pens Price: by Type, 2020-2021 (USD/Unit)

    Table 31. Global Insulin Delivery Pens Market Size by Application: 2020-2021 (US$ Million)

    Table 32. Global Insulin Delivery Pens Market Size by Application, 2020-2021 (K Units)

    Table 33. Global Insulin Delivery Pens Price: by Application, 2020-2021 (USD/Unit)

    Table 34. Global Insulin Delivery Pens Market Size by Region, 2019-2021 (US$ Million)

    Table 35. Global Insulin Delivery Pens Market Size by Region, 2019-2021 (K Units)

    Table 36. By Country, North America Insulin Delivery Pens Market Size, 2019-2021 (US$ Million)

    Table 37. By Country, North America Insulin Delivery Pens Market Size, 2019-2021 (K Units)

    Table 38. US Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 39. Canada Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

    Table 41. By Country, Europe Insulin Delivery Pens Market Size, 2019-2021 (US$ Million)

    Table 42. By Country, Europe Insulin Delivery Pens Market Size, 2019-2021 (K Units)

    Table 43. Germany Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 44. France Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 45. UK Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 46. Italy Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    Table 48. By Region, Asia-Pacific Insulin Delivery Pens Market Size, 2019-2021 (US$ Million)

    Table 49. By Region, Asia-Pacific Insulin Delivery Pens Market Size, 2019-2021 (K Units)

    Table 50. China Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 51. Japan Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 52. South Korea Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 53. India Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 54. ASEAN Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 55. Latin America Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 56. Middle East and Africa Insulin Delivery Pens Market Size, 2019-2021 (US$ Million) & (K Units)

    Table 57. Novo Nordisk Business Overview

    Table 58. Novo Nordisk Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 59. Novo Nordisk Insulin Delivery Pens Product

    Table 60. Novo Nordisk Response to COVID-19 and Related Developments

    Table 61. Sanofi Diabetes Business Overview

    Table 62. Sanofi Diabetes Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 63. Sanofi Diabetes Insulin Delivery Pens Product

    Table 64. Sanofi Diabetes Response to COVID-19 and Related Developments

    Table 65. Medtronic Business Overview

    Table 66. Medtronic Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 67. Medtronic Insulin Delivery Pens Product

    Table 68. Medtronic Response to COVID-19 and Related Developments

    Table 69. BD Business Overview

    Table 70. BD Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 71. BD Insulin Delivery Pens Product

    Table 72. BD Response to COVID-19 and Related Developments

    Table 73. Animas Business Overview

    Table 74. Animas Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 75. Animas Insulin Delivery Pens Product

    Table 76. Animas Response to COVID-19 and Related Developments

    Table 77. Roche Business Overview

    Table 78. Roche Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 79. Roche Insulin Delivery Pens Product

    Table 80. Roche Response to COVID-19 and Related Developments

    Table 81. Insulet Business Overview

    Table 82. Insulet Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 83. Insulet Insulin Delivery Pens Product

    Table 84. Insulet Response to COVID-19 and Related Developments

    Table 85. Bomtech Business Overview

    Table 86. Bomtech Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 87. Bomtech Insulin Delivery Pens Product

    Table 88. Bomtech Response to COVID-19 and Related Developments

    Table 89. BioSampling Business Overview

    Table 90. BioSampling Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 91. BioSampling Insulin Delivery Pens Product

    Table 92. BioSampling Response to COVID-19 and Related Developments

    Table 93. Cardiocomm Solutions Business Overview

    Table 94. Cardiocomm Solutions Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 95. Cardiocomm Solutions Insulin Delivery Pens Product

    Table 96. Cardiocomm Solutions Response to COVID-19 and Related Developments

    Table 97. Henke-Sass Business Overview

    Table 98. Henke-Sass Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 99. Henke-Sass Insulin Delivery Pens Product

    Table 100. Henke-Sass Response to COVID-19 and Related Developments

    Table 101. Kavo Business Overview

    Table 102. Kavo Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 103. Kavo Insulin Delivery Pens Product

    Table 104. Kavo Response to COVID-19 and Related Developments

    Table 105. Megasan Medical Business Overview

    Table 106. Megasan Medical Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 107. Megasan Medical Insulin Delivery Pens Product

    Table 108. Megasan Medical Response to COVID-19 and Related Developments

    Table 109. Nipro Business Overview

    Table 110. Nipro Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 111. Nipro Insulin Delivery Pens Product

    Table 112. Nipro Response to COVID-19 and Related Developments

    Table 113. Mika Medical Business Overview

    Table 114. Mika Medical Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 115. Mika Medical Insulin Delivery Pens Product

    Table 116. Mika Medical Response to COVID-19 and Related Developments

    Table 117. Rudolf Riester Business Overview

    Table 118. Rudolf Riester Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 119. Rudolf Riester Insulin Delivery Pens Product

    Table 120. Rudolf Riester Response to COVID-19 and Related Developments

    Table 121. Smiths Medical Business Overview

    Table 122. Smiths Medical Insulin Delivery Pens Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 123. Smiths Medical Insulin Delivery Pens Product

    Table 124. Smiths Medical Response to COVID-19 and Related Developments

    Table 125. Insulin Delivery Pens Distributors List

    Table 126. Insulin Delivery Pens Customers List

    Table 127. Covid-19 Impact on Insulin Delivery Pens Customers

List of Figures

    Figure 1. Insulin Delivery Pens Product Picture

    Figure 2. Insulin Delivery Pens Market Segmentation

    Figure 3. Research Objectives

    Figure 4. Research Process

    Figure 5. Data Triangulation

    Figure 6. Research Approach

    Figure 7. Commodity Prices-Metals Price Indices

    Figure 8. Commodity Prices- Precious Metal Price Indices

    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

    Figure 10. Commodity Prices- Food and Beverage Price Indices

    Figure 11. Commodity Prices- Fertilizer Price Indices

    Figure 12. Commodity Prices- Energy Price Indices

    Figure 13. G20+: Economic Policy Responses to COVID-19

    Figure 14. Global Insulin Delivery Pens Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

    Figure 15. Global Insulin Delivery Pens Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

    Figure 16. Global Insulin Delivery Pens Market Size, Quarterly Growth, 2020-2021 (%)

    Figure 17. Global Insulin Delivery Pens Market Size, Market Share by Type, 2019 VS 2020 (%)

    Figure 18. Global Insulin Delivery Pens Market Size, Market Share by Application, 2019 VS 2020 (%)

    Figure 19. Global Insulin Delivery Pens Market Size Market Share by Region, 2019 VS 2020 (%)

    Figure 20. United States Composite PMI and GDP

    Figure 21. Eurozone Composite PMI and GDP

    Figure 22. Eurozone Core v. Periphery PMI Output Indices

    Figure 23. Core v. Periphery PMI Employment Indices

    Figure 24. UK Composite PMI and GDP

    Figure 25. Caixin China Composite Output Index

    Figure 26. Caixin China General Services Business Activity Index

    Figure 27. Japan Composite Output Index

    Figure 28. South Korea Manufacturing PMI

    Figure 29. India Composite Output Index

    Figure 30. ASEAN Manufacturing PMI

    Figure 31. By Region, Asia-Pacific Insulin Delivery Pens Market Size Market Share, 2019-2021